Covance has expanded its drug metabolism services to include drug-transporter interactions with eight human transporters. The company now offers assessment of drug-transporter interactions involving major human transporters key to drug disposition in a stably transfected, cell-based format. “For more than 30 years, Covance has helped our clients achieve a detailed understanding of the disposition of their drug candidates,” said Jon Denissen, Ph.D., vice president of Global Drug Metabolism. “The...